PIPE Securities Purchase Agreement (US Issuer)
A public company's private-placement stock purchase agreement with accredited investors, including full 2026-current representations, a registration-rights covenant package, and MFN, variable-rate and subsequent-placement restrictions.
What is a PIPE Securities Purchase Agreement?
A PIPE Securities Purchase Agreement (US Issuer) is a public company's private-placement stock purchase agreement with accredited investors, including full 2026-current representations, a registration-rights covenant package, and MFN, variable-rate and subsequent-placement restrictions.
Built for a US-listed public company issuing common stock (and often warrants or pre-funded warrants) in a private placement to one or more accredited institutional investors, typically with a mandatory resale registration statement to follow.
PIPE Securities Purchase Agreement template, current for 2026
Reflects the 2026-current SEC disclosure regime, including cybersecurity incident reporting under Item 1.05 of Form 8-K and Item 1C of Form 10-K, Inline XBRL compliance, tightened variable-rate-transaction and MFN mechanics that survived recent short-seller litigation, and a modernized Regulation FD/8-K public-announcement covenant coordinated with the pre-signing shorting-window rep.
How HDAi does this differently
Unlike a static form, HDAi runs a guided interview and assembles your PIPE Securities Purchase Agreement as you answer. When you want it finished, a licensed Hart David Carson attorney reviews it and tailors it to your facts before you sign. The interview and the first draft are automated. The judgment belongs to an attorney.
What you’ll be asked
- Full legal name of the issuer (the public company)? The SEC-registered issuer. Use the exact charter name; this shows up on every legend and every filing.
- State of incorporation? Governs internal affairs. Delaware for the majority of listed issuers; a Nevada or other-state issuer changes some reps.
- On which exchange are the shares listed? Drives the Minimum Price (5635(d)) rep, the 19.99% cap analysis, the shareholder-approval covenants (Nasdaq 5635(c)/(d) / NYSE 312.03), and the Listing of Additional Shares filing.
- Trading symbol? Used in the recitals and covenants referring to the listing.
- Signing date of this agreement? Also anchors the pre-signing shorting window, the MFN look-back, and the Minimum Price measurement date under exchange rules.
- Is this offering being conducted under Rule 506(b) or Rule 506(c)? Rule 506(b) prohibits general solicitation and lets you rely on investor accreditation self-certification. Rule 506(c) permits general solicitation but requires the issuer (or the placement agent) to take reasonable steps to VERIFY each purchaser's accredited-investor status. State this expressly; do not plead a generic 'Rule 506'. If in doubt, most negotiated PIPEs are 506(b).
- For a Rule 506(c) offering, how will accredited-investor status be verified? Rule 506(c) requires reasonable steps to verify. Common methods are a review of tax or income documents, a written confirmation from a registered broker-dealer, SEC-registered investment adviser, licensed attorney, or CPA, and, for institutional purchasers, reliance on a QIB or registered-adviser status representation. Only shown for 506(c).
- Has the Company completed a Rule 506(d) 'bad actor' screen of all covered persons (directors, executive and participating officers, 20% beneficial owners, promoters, and any placement agent and its principals), including pre-signing D&O and 20%-holder questionnaires? Rule 506(d) disqualifies the entire Regulation D exemption if any 'covered person' has a disqualifying event under Rule 506(d)(1)(i)-(viii). Rule 506(e) requires the issuer to exercise reasonable care (typically factual-inquiry questionnaires) to determine that no such event exists. This is the one exemption-breaking item; the agreement includes a rep and a notice covenant keyed to it.
- How will closing be handled? T+1/T+2 direct wire is standard for small PIPEs; escrow is used when there are many investors or when a minimum offering amount must be reached before release.
- Escrow agent (if applicable)? Named in the escrow-release mechanics.
- Minimum offering amount to trigger release?
- What securities are being sold? Pre-funded warrants (nominal exercise, e.g. $0.0001) are used when an investor would otherwise cross a 4.99%/9.99% beneficial-ownership blocker.
- Number of shares of common stock being sold?
- Purchase price per share (or per share + accompanying warrant unit)? Under Nasdaq 5635(d) / NYSE 312.03(c), the price must be at or above the Minimum Price (broadly, the lower of the official closing price immediately before signing or the five-trading-day average) to issue 20% or more without a shareholder vote. This value drives the operative Minimum-Price rep and the exchange-cap covenant.
- Aggregate purchase price?
- Warrant coverage (e.g., 50%) and exercise price?
- How many investors are signing? Changes drafting conventions but not the substance. A single-investor SPA reads differently from a multi-investor form.
- Lead investor (or sole investor) legal name?
- How many calendar days after Closing must the resale registration statement be filed? Market standard is 30 days for filing; effectiveness deadline typically 90 days (or 120 if the SEC reviews).
- Effectiveness deadline (days after Closing)?
- Registration-default liquidated damages rate (monthly, capped)? Common range: 1% per month capped at 6-10% of the aggregate purchase price. Delay caused by the SEC's Rule 415 cutback is generally excluded.
- Pre-signing shorting-lookback window (days)? The investor reps that from the specified day before signing through public announcement it has not effected a short sale or hedge in the issuer's securities. Ten trading days is common.
- MFN window for subsequent PIPEs (days after Closing)? If the issuer does a more favorable subsequent PIPE within this window, the investor gets the better economics. Increasingly contested; sophisticated issuers push back or narrow the definition of Subsequent Placement.
- Variable-rate transaction ban duration (months after Closing)? Prohibits equity lines, floorless converts, and Yorkville-style facilities during the window. Standard investor ask.
- General subsequent-placement lockup (days after Closing)? The issuer agrees not to sell equity for this many days after Closing (excluding exempt issuances: options, M&A, strategic partners).
- Governing law? New York is standard for PIPEs whatever the issuer's state of incorporation.
- Dispute resolution?
- Was there a placement agent? Adds a rep about broker-dealer fees, a reference to the placement-agent engagement letter, and treats the agent and its principals as Rule 506(d) covered persons.
- Placement agent name?